Filing Details
- Accession Number:
- 0001140361-15-028270
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-22 15:21:57
- Reporting Period:
- 2015-07-20
- Filing Date:
- 2015-07-22
- Accepted Time:
- 2015-07-22 15:21:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 770 Lindaro St. San Rafael CA 94901 | Svp, Chief Commercial Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-20 | 3,000 | $63.10 | 38,605 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-07-20 | 3,000 | $150.00 | 35,605 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) Common Stock | Disposition | 2015-07-20 | 3,000 | $0.00 | 3,000 | $63.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,700 | 2014-12-04 | 2024-06-03 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed Mayy 11, 2015
- All shares sold at the same price
- Original option grant vests 6/48ths on December 4, 2014 and 1/48th on the 4th fay of ever month thereafter.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transactions.
Billionaire Hedge Funds
